DrugPatentWatch Database Preview
Patent: 6,255,067
» See Plans and Pricing
Summary for Patent: 6,255,067
Title: | cDNA encoding peptidyl-glycine alpha-amidating monooxygenase (PAM) |
Abstract: | The sequence of bovine PAM is taught as well as new forms of PAM not known before. One new form is membrane bound and provides the basis of methods for alpha-amidating inactive precursors of peptide hormones. |
Inventor(s): | Keutmann; Henry T. (Concord, MA), Schofield; Peter (Heidelberg, DE), Rodriguez; Henry (Belmont, CA), Eipper; Betty (Baltimore, MD), Mains; Richard (Baltimore, MD) |
Assignee: | The Johns Hopkins University (Baltimore, MD) |
Application Number: | 07/096,447 |
Patent Claims: | see list of patent claims |
Details for Patent 6,255,067
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 003 | 1986-06-04 | Start Trial | The Johns Hopkins University (Baltimore, MD) | 2039-02-26 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 002 | 1986-06-04 | Start Trial | The Johns Hopkins University (Baltimore, MD) | 2039-02-26 | RX | search | |
Schering | INTRON A | interferon alfa-2b | VIAL | 103132 | 001 | 1986-06-04 | Start Trial | The Johns Hopkins University (Baltimore, MD) | 2039-02-26 | RX | search | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 6,255,067
Country | Patent Number | Estimated Expiration |
---|---|---|
World Intellectual Property Organization (WIPO) | 8902460 | Start Trial |
Japan | H03501205 | Start Trial |
European Patent Office | 0382766 | Start Trial |
Germany | 3856069 | Start Trial |
>Country | >Patent Number | >Estimated Expiration |